Advanced Medical Isotope Net Income/Loss 2013-2025 | RDGL

Advanced Medical Isotope net income/loss from 2013 to 2025. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement

Advanced Medical Isotope Net Income/Loss 2013-2025 | RDGL

Advanced Medical Isotope net income/loss from 2013 to 2025. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
Related Stocks
Company NameMarket
Cap
Ares Capital (ARCC)$14B
Blackstone Secured Lending Fund (BXSL)$6.6B
FS KKR Capital (FSK)$5.5B
Main Street Capital (MAIN)$4.7B
Golub Capital BDC (GBDC)$3.8B
Hercules Capital (HTGC)$3.1B
Sixth Street Specialty Lending (TSLX)$1.9B
Morgan Stanley Direct Lending Fund (MSDL)$1.7B
Goldman Sachs BDC (GSBD)$1.2B
Kayne Anderson BDC (KBDC)$1.1B
New Mountain Finance (NMFC)$1.1B
Bain Capital Specialty Finance (BCSF)$967M
BARINGS BDC, INC (BBDC)$917M
Trinity Capital (TRIN)$900M
Amalgamated Financial (AMAL)$820M
Nuveen Churchill Direct Lending (NCDL)$777M
Carlyle Secured Lending (CGBD)$743M
Fidus Investment (FDUS)$644M
BLACKROCK TCP CAPITAL CORP (TCPC)$578M
Crescent Capital BDC (CCAP)$574M
Gladstone Capital (GLAD)$556M
Gladstone Investment (GAIN)$512M
CION Investment (CION)$501M
Palmer Square Capital BDC (PSBD)$418M
PennantPark Investment (PNNT)$413M
Stellus Capital Investment (SCM)$351M
Runway Growth Finance (RWAY)$343M
Horizon Technology Finance (HRZN)$338M
Saratoga Investment Corp (SAR)$337M
TriplePoint Venture Growth BDC (TPVG)$240M